Establishment of overexpressing <i>RP11-502I4.3</i> model in rats. by Lan Zeng (638254)

Subjects:

Detection of changes in <i>vascular endothelial growth factor</i> (<i>VEGF</i>) and <i>RP11-502I4.3</i> expression levels. by Lan Zeng (638254)

Subjects:

Establishment of overexpressing <i>RP11-502I4.3</i> model in human retinal microvascular endothelial cells (HRMECs). by Lan Zeng (638254)

Subjects:

Expression levels of <i>RP11-502I4.3</i> in the human vitreous humor (VH) of patients with proliferative diabetic retinopathy (PDR). by Lan Zeng (638254)

Subjects:

Establishment of a diabetic rat model. by Lan Zeng (638254)

Subjects:

Primer sequence for quantitative real-time polymerase chain reaction. by Lan Zeng (638254)

Subjects:

Overexpressing <i>RP11-502I4.3</i> inhibited the trend of angiogenesis in rats. by Lan Zeng (638254)

Subjects:

<b>Manure improves temperature sensitivity of soil organic carbon by increasing soil alphaproteobacteria, phenols, and pH and decreasing soil esters</b> by Andong Cai (5237024)

“…The results revealed that the Q₁₀ under M and NPKM were 1.59 and 1.66, respectively, which were significantly higher than those under CK (1.35), N (1.29), and NPK (1.36). …”

Survival function analysis of mortality for Viral load status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Multivariate Cox proportional hazard analysis ratio of patient factors associated with treatment outcomes in HIV care, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Clinic characteristics of study participants from two ART facilities in Bauchi state, based on data retrieved covering a three-year period from 2020 to 2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of treatment Interruption for Viral load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of viral suppression for BMI status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Schematic presentation of sampling of population for analysis. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival curve of ART Treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of mortality and viral load suppression by demographic characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of ART treatment interruption and LTFU by clinical characteristics <i>among participants in HIV care Facilities in</i> Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of ART treatment interruption and LTFU by demographic characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of mortality and viral load suppression by clinical characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. by Ekerette Emmanuel Udoh (7326194)

Subjects: